CASE REPORTS
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Reconstruction of superior vena cava syndrome due to benign disease using superficial femoral vein.

Superior vena cava (SVC) syndrome due to benign disease requires prompt and durable treatment because affected patients frequently have long life expectancies. While conservative management with head elevation and anticoagulation are first-line treatments, refractory symptoms may warrant intervention. The two main invasive treatments are percutaneous endovascular repair and open surgical reconstruction. Both have demonstrated efficacy over the mid term, but surgical reconstruction is the only method with proved patency over the long term. This report documents a case of a 26-year-old woman with SVC syndrome secondary to long-term indwelling central venous catheterization. SVC bypass was performed using the superficial femoral vein, and near-complete resolution of symptoms occurred within 1 week. Superficial femoral vein is a versatile conduit for SVC reconstruction and a useful alternative to spiral saphenous vein grafts, although mid- and long-term patency rates must be further studied.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app